Oncology Medical News about pancreatic cancer growth

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Intratumoral delivery of shRNA targeting cyclin D1 attenuates pancreatic cancer growth
Cancer Gene Therapy, 10/27/09

Deharvengt SJ et al. – It is concluded that lentivirus–delivered shRNA targeting cyclin D1 suppresses the growth, invasiveness, tumorigenicity and pro–angiogenic potential of human pancreatic cancer cells, thereby raising the possibility that intratumoral injections of viruses targeting cyclin D1 could provide a new therapeutic approach in pancreatic ductal adenocarcinoma.

<< Previous
JAK2 germline genetic variation affects disease susceptibility in...

Next >>
Malignant melanoma: A retrospective series from a regional cancer...

Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer
Journal of Clinical Oncology, 11/03/09 Relevance Score: 81%

Blockade of MGMT Expression by O6 Benzyl Guanine Leads to Inhibition of Pancreatic Cancer Growth and Induction of Apoptosis
Clinical Cancer Research, 10/01/09 Relevance Score: 81%

Real-time and the in vivo detection of minute cancer invasion to the portal-superior mesenteric vein using contact endoscopy during a pancreatic cancer resection
The American Journal of Surgery, 11/06/09 Relevance Score: 70%

Familial association of pancreatic cancer with other malignancies in Swedish families
British Journal of Cancer, 10/15/09 Relevance Score: 70%

Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma
Journal of Gastroenterology, 10/02/09 Relevance Score: 69%